Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia.

MLA

Steinbach, Alison, et al. “Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia.” JADPRO: Journal of the Advanced Practitioner in Oncology, vol. 4, no. 6, Nov. 2013, pp. 451–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=109133244&authtype=sso&custid=ns315887.

APA

Steinbach, A., Clark, S. M., & Clemmons, A. B. (2013). Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia. JADPRO: Journal of the Advanced Practitioner in Oncology, 4(6), 451–455.

Chicago

Steinbach, Alison, Stephen M. Clark, and Amber B. Clemmons. 2013. “Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia.” JADPRO: Journal of the Advanced Practitioner in Oncology 4 (6): 451–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=109133244&authtype=sso&custid=ns315887.